PA
HLN icon

PharVision Advisers’s Haleon HLN Stock Holding History

PharVision Advisers’s Portfolio HLN Stock Details HLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$123K Buy
+12,303
New +$128K 1.25% 30

Other funds holding HLN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

PharVision Advisers's HLN Position: Q1 2026 in Review

PharVision Advisers opened a new position in Haleon (HLN) in Q1 2026: 12,303 shares worth $123K. The stake represents 1.25% of the portfolio and ranks #30 among its holdings.

619 funds tracked by Wall St. Rank hold HLN as of Q1 2026.

  • PharVision Advisers held 12,303 shares of Haleon worth $123K as of Q1 2026.
  • Haleon was a new PharVision Advisers position in Q1 2026.
  • Haleon made up 1.25% of PharVision Advisers's portfolio in Q1 2026, its #30 holding.
  • 619 funds tracked by Wall St. Rank held Haleon as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.